Dilazep
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
 | |
| Clinical data | |
|---|---|
| Trade names | Comelian Kowa |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C31H44N2O10 |
| Molar mass | 604.697 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
It is used for the treatment of cardiopathy and renal disorders.[2]
See also
- Hexobendine, a drug with similar chemical structure
References
- Deguchi H, Takeya H, Wada H, Gabazza EC, Hayashi N, Urano H, Suzuki K (September 1997). "Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes". Blood. 90 (6): 2345–56. doi:10.1182/blood.V90.6.2345. PMID 9310485.
- "Pharmaceuticals". Kowa Company Ltd.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.